Skip to content

Effect of Force Magnitude on Canine Retraction and Gingival Crevicular Fluid Proteome

A Randomized Clinical Trial Comparing the Effect of Force Magnitude on the Rate of Canine Retraction and Gingival Crevicular Fluid Proteome Profile

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06668194
Enrollment
40
Registered
2024-10-31
Start date
2024-11-13
Completion date
2028-04-01
Last updated
2024-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Crowding

Keywords

Orthodontic space closure, Canine retraction, Gingival crevicular fluid, Proteomics

Brief summary

This study aims to examine the effect of force levels in orthodontic treatment during canine retraction. Force levels refer to the pressure applied by the orthodontic devices to move teeth. Data collection will include gingival fluid, dental molds from a digital scanner, and x-rays of the upper canine region on both sides of the mouth during treatment. The null hypothesis to be tested is that there is no significant difference in the rate of canine movement between the light force and the heavy force levels.

Detailed description

Patients' participation in the study at the first visit (T0) Timepoint 0, will be started at the stage of canine retraction. At this appointment, 0.019 x 0.025-inch stainless steel archwire will be placed; power arms will be fabricated from 17x25-inch stainless steel on the maxillary first molars and canines. The height of the power arm will be matched with the center of resistance of both canines and molars based on the root length measured on the periapical radiographs. The archwire will be engaged in the canine bracket using stainless steel ligature wire. At the T0 appointment, before applying the retraction force, periapical radiographs of canines (with coronal and apical reference wires for calibration and magnification correction) and GCF (gingival crevicular fluid) samples of each canine will be collected. Gingival sulcus of mesial and distal to canine (bilaterally) will be chosen as sites for GCF sample collection. The study coordinator will take a digital scan using iTero® Element™ in the clinic as the baseline (T0). As the split-mouth design will be applied in this study, right and left sides will be assigned randomly for either 150gm (light force) or 400gm force (heavy force) for each subject. NiTi coil spring calibrated for force magnitude at oral temperature will be used to deliver the assigned force will be engaged from the first molars to the canine power arms. IRB-approved written instructions will also be provided to all the participants. Follow-up visits will be scheduled. After applying the force, follow-up visits will be scheduled at (T1) 1-2 weeks, (T2) 4-5 weeks, (T3) 8-9 weeks, (T4)12-13 weeks, and (T5)16-17 weeks. A new digital scan will be taken at each study appointment (T0 - T5). These digital scans will be used for tooth movement measurements. GCF samples (mesial and distal to canines bilaterally) will be collected only for the first 3 appointments (T0 - T2) for the first 10 participants only in this study. Periapical radiographs for canines on both sides will be obtained on (T0) Timepoint 0, and (T3) 8-9 weeks and (T5) 16-17 weeks of the study for each participant and analyzed to measure the EARR (external apical root resorption). Following the last study visit, all subjects' treatment will continue as recommended by the primary orthodontic care provider. No new data will be reviewed or collected after (T5).

Interventions

DEVICELight Force (150g Niti Coil)

Patients' participation in the study (T0) will be started at the stage of canine retraction. At this appointment, 0.019 x 0.025-inch stainless steel archwire will be placed; power arms will be fabricated from 17x25-inch stainless steel on the maxillary first molars and canines. The height of the power arm will be matched with the center of resistance of both canines and molars based on the root length measured on the periapical radiographs. The archwire will be engaged in the canine bracket using stainless steel ligature wire. NiTi coil spring calibrated for force magnitude (150g) at oral temperature will be used to deliver the assigned force will be engaged from the first molars to the canine power arms

DEVICEHeavy Force (400 g Niti coil)

Patients' participation in the study (T0) will be started at the stage of canine retraction. At this appointment, 0.019 x 0.025-inch stainless steel archwire will be placed; power arms will be fabricated from 17x25-inch stainless steel on the maxillary first molars and canines. The height of the power arm will be matched with the center of resistance of both canines and molars based on the root length measured on the periapical radiographs. The archwire will be engaged in the canine bracket using stainless steel ligature wire. NiTi coil spring calibrated for force magnitude (400g) at oral temperature will be used to deliver the assigned force will be engaged from the first molars to the canine power arms

Sponsors

Charles Burstone Foundation
CollaboratorUNKNOWN
UConn Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Split mouth design

Eligibility

Sex/Gender
ALL
Age
11 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy patient, non-smoker * Age: 11 - 16 years of age, inclusive. * A full complement of dentition (central incisor to 1st molar) in the four quadrants, except second molars * Patients requiring at least upper bilaterally maxillary 1st premolar extraction as a treatment plan (Class I bimaxillary protrusion/ crowding or Class II maxillary dentoalveolar protrusion/ crowding) * At least 5 mm of space left between canine and 2nd premolar to be closed at the time of canine retraction * At least six months after the extraction of first premolars and in a 0.019 x 0.025-inch stainless steel archwire in the maxilla * The ability to read and understand English and to provide informed consent

Exclusion criteria

* Patients under 11 years of age and over the age of 16. * Non-extraction treatment plan * Extraction of maxillary tooth other than first premolars bilaterally. * Evidence of poor oral hygiene * Evidence of previous root resorption * Missing or impacted tooth in any of the quadrant except 3rd molars. * Medical issues that affect tooth movement * Inability to provide oral and written consent to participate. * Patient on medications that may alter bone metabolisms like bisphosphonates, oral contraceptives, or PTH (parathyroid hormone) * Chronic illness or syndromic patients. * Pregnant women, prisoners, and decisional impaired

Design outcomes

Primary

MeasureTime frameDescription
Rate of Canine retraction16-17 weeksAmount of canine distal displacement in all 3 dimensions with 6 degrees of freedom will be measured through 17 weeks
Gingival crevicular fluid proteomic analysis4-5 weeksCollected GCF samples from time point (T0, T1 and T2) and same sides (left or right) and aspect of tooth (mesial or distal) from 10 patients for each of the maxillary canines (total of 12 samples per patient). GCF will be collected for the following time points: T0, T1, and T3. A total of 120 samples will be sent for a non-labeled method of proteomic analysis. This will indicate the change in expression of various proteins in GCF samples throughout treatment.

Secondary

MeasureTime frameDescription
External apical root resorption (EARR)16-17 weeksThe amount of root resorption on the canines as they are being retracted will be measured radiographically before starting retraction, at 8-9 weeks, and at 16-17 weeks.
Maxillary first molar 3 dimensional displacement16-17 weeksMaxillary first molar displacement in response to a heavy and light force will be characterized in 3D through the 17 weeks.

Countries

United States

Contacts

Primary ContactFlavio Uribe, DDS, MDentSc
furibe@uchc.edu860-679-2664
Backup ContactGeorgiana Defilio
860-679-2550

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026